Identification of Plausible Candidates in Prostate Cancer Using Integrated Machine Learning Approaches

被引:2
|
作者
Kour, Bhumandeep [1 ,2 ]
Shukla, Nidhi [2 ,3 ]
Bhargava, Harshita [4 ]
Sharma, Devendra [5 ]
Sharma, Amita [4 ]
Singh, Anjuvan [6 ]
Valadi, Jayaraman [7 ]
Sadasukhi, Trilok Chand [8 ]
Vuree, Sugunakar [2 ,9 ]
Suravajhala, Prashanth [2 ,10 ]
机构
[1] Lovely Profess Univ, Dept Biotechnol, Jalandhar, Punjab, India
[2] Bioclues Org, Hyderabad, India
[3] Birla Inst Sci Res, Dept Biotechnol & Bioinformat, Jaipur, Rajasthan, India
[4] IIS Univ, Dept Comp Sci, Jaipur, Rajasthan, India
[5] Rukmani Birla Hosp, Urol & Renal Transplant Dept Renal Sci, Jaipur, Rajasthan, India
[6] Lovely Profess Univ, Sch Bioengn & Biosci, Dept Biotechnol, Phagwara 144001, Punjab, India
[7] FLAME Univ, Dept Comp Sci, Pune, Maharashtra, India
[8] Mahatma Gandhi Univ Med Sci & Technol, Dept Urol & Renal Transplant, Jaipur, Rajasthan, India
[9] MNR Univ, MNR Med Coll & Hosp, MNR Fdn Res & Innovat, Fasalwadi, Telangana, India
[10] Amrita Vishwa Vidyapeetham, Amrita Sch Biotechnol, Kollam, Kerala, India
关键词
cBioPortal; prostate cancer; biomarkers; machine learning; bioinformatics; Prostate-Specific Antigens (PSA); GLYCATED HEMOGLOBIN; MOLECULAR-MECHANISMS; RISK; OBESITY; MULTIPLE; SERVER; COUNT; HBA1C;
D O I
10.2174/0113892029240239231109082805
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background Currently, prostate-specific antigen (PSA) is commonly used as a prostate cancer (PCa) biomarker. PSA is linked to some factors that frequently lead to erroneous positive results or even needless biopsies of elderly people.Objectives In this pilot study, we undermined the potential genes and mutations from several databases and checked whether or not any putative prognostic biomarkers are central to the annotation. The aim of the study was to develop a risk prediction model that could help in clinical decision-making.Methods An extensive literature review was conducted, and clinical parameters for related comorbidities, such as diabetes, obesity, as well as PCa, were collected. Such parameters were chosen with the understanding that variations in their threshold values could hasten the complicated process of carcinogenesis, more particularly PCa. The gathered data was converted to semi-binary data (-1, -0.5, 0, 0.5, and 1), on which machine learning (ML) methods were applied. First, we cross-checked various publicly available datasets, some published RNA-seq datasets, and our whole-exome sequencing data to find common role players in PCa, diabetes, and obesity. To narrow down their common interacting partners, interactome networks were analysed using GeneMANIA and visualised using Cytoscape, and later cBioportal was used (to compare expression level based on Z scored values) wherein various types of mutation w.r.t their expression and mRNA expression (RNA seq FPKM) plots are available. The GEPIA 2 tool was used to compare the expression of resulting similarities between the normal tissue and TCGA databases of PCa. Later, top-ranking genes were chosen to demonstrate striking clustering coefficients using the Cytoscape-cytoHubba module, and GEPIA 2 was applied again to ascertain survival plots.Results Comparing various publicly available datasets, it was found that BLM is a frequent player in all three diseases, whereas comparing publicly available datasets, GWAS datasets, and published sequencing findings, SPFTPC and PPIMB were found to be the most common. With the assistance of GeneMANIA, TMPO and FOXP1 were found as common interacting partners, and they were also seen participating with BLM.Conclusion A probabilistic machine learning model was achieved to identify key candidates between diabetes, obesity, and PCa. This, we believe, would herald precision scale modeling for easy prognosis.
引用
收藏
页码:287 / 306
页数:20
相关论文
共 50 条
  • [41] Identification of thyroid cancer biomarkers using WGCNA and machine learning
    Hu, Gaofeng
    Niu, Wenyuan
    Ge, Jiaming
    Xuan, Jie
    Liu, Yanyang
    Li, Mengjia
    Shen, Huize
    Ma, Shang
    Li, Yuanqiang
    Li, Qinglin
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2025, 30 (01)
  • [42] Identification of miRNA-Mediated Subpathways as Prostate Cancer Biomarkers Based on Topological Inference in a Machine Learning Process Using Integrated Gene and miRNA Expression Data
    Ning, Ziyu
    Yu, Shuang
    Zhao, Yanqiao
    Sun, Xiaoming
    Wu, Haibin
    Yu, Xiaoyang
    FRONTIERS IN GENETICS, 2021, 12
  • [43] Melanoma Skin Cancer Identification using Machine Learning Technique
    Lakshmi, R.
    Arthi, B.
    2ND INTERNATIONAL CONFERENCE ON SUSTAINABLE COMPUTING AND SMART SYSTEMS, ICSCSS 2024, 2024, : 951 - 956
  • [44] Breast Cancer Classification: Features Investigation Using Machine Learning Approaches
    Mashudi, Nurul Amirah
    Rossli, Syaidathul Amaleena
    Ahmad, Norulhusna
    Noor, Norliza Mohd
    INTERNATIONAL JOURNAL OF INTEGRATED ENGINEERING, 2021, 13 (05): : 107 - 118
  • [45] Prediction of cancer using customised fuzzy rough machine learning approaches
    Arunkumar, Chinnaswamy
    Ramakrishnan, Srinivasan
    HEALTHCARE TECHNOLOGY LETTERS, 2019, 6 (01): : 13 - 18
  • [46] Study of prognostic splicing factors in cancer using machine learning approaches
    Yang, Mengyuan
    Liu, Jiajia
    Kim, Pora
    Zhou, Xiaobo
    HUMAN MOLECULAR GENETICS, 2024, 33 (13) : 1131 - 1141
  • [47] Age-specific survival in prostate cancer using machine learning
    Doja, M. N.
    Kaur, Ishleen
    Ahmad, Tanvir
    DATA TECHNOLOGIES AND APPLICATIONS, 2020, 54 (02) : 215 - 234
  • [48] Predicting intermediate-risk prostate cancer using machine learning
    Stojadinovic, Miroslav
    Stojadinovic, Milorad
    Jankovic, Slobodan
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2025, : 1737 - 1746
  • [49] Diagnosis of prostate cancer in a Chinese population by using machine learning methods
    Wang, Guanjin
    Teoh, Jeremy Yuen-Chun
    Choi, Kup-Sze
    2018 40TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2018, : 3971 - 3974
  • [50] Automatic Gleason grading of prostate cancer using SLIM and machine learning
    Nguyen, Tan H.
    Sridharan, Shamira
    Marcias, Virgilia
    Balla, Andre K.
    Do, Minh N.
    Popescu, Gabriel
    QUANTITATIVE PHASE IMAGING II, 2016, 9718